ID: ALA208514

Max Phase: Preclinical

Molecular Formula: C16H14O

Molecular Weight: 222.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H](O)c1cc2ccccc2c2ccccc12

Standard InChI:  InChI=1S/C16H14O/c1-11(17)16-10-12-6-2-3-7-13(12)14-8-4-5-9-15(14)16/h2-11,17H,1H3/t11-/m0/s1

Standard InChI Key:  NEARLFKSRGYLGW-NSHDSACASA-N

Associated Targets(Human)

UDP-glucuronosyltransferase 2B17 197 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 222.29Molecular Weight (Monoisotopic): 222.1045AlogP: 4.05#Rotatable Bonds: 1
Polar Surface Area: 20.23Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.60CX LogD: 3.60
Aromatic Rings: 3Heavy Atoms: 17QED Weighted: 0.62Np Likeness Score: 0.11

References

1. Bichlmaier I, Siiskonen A, Finel M, Yli-Kauhaluoma J..  (2006)  Stereochemical sensitivity of the human UDP-glucuronosyltransferases 2B7 and 2B17.,  49  (5): [PMID:16509597] [10.1021/jm051142c]

Source